278 related articles for article (PubMed ID: 17091128)
1. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
Haney M
Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
[TBL] [Abstract][Full Text] [Related]
2. Interaction between naltrexone and oral THC in heavy marijuana smokers.
Haney M; Bisaga A; Foltin RW
Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
[TBL] [Abstract][Full Text] [Related]
3. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper ZD; Haney M
Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
Ranganathan M; Carbuto M; Braley G; Elander J; Perry E; Pittman B; Radhakrishnan R; Sewell RA; D'Souza DC
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1251-64. PubMed ID: 22243563
[TBL] [Abstract][Full Text] [Related]
5. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
Wachtel SR; de Wit H
Drug Alcohol Depend; 2000 Jun; 59(3):251-60. PubMed ID: 10812285
[TBL] [Abstract][Full Text] [Related]
6. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
Wakley AA; Craft RM
Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
[TBL] [Abstract][Full Text] [Related]
7. The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.
Justinova Z; Tanda G; Munzar P; Goldberg SR
Psychopharmacology (Berl); 2004 Apr; 173(1-2):186-94. PubMed ID: 14668977
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute smoked marijuana on complex cognitive performance.
Hart CL; van Gorp W; Haney M; Foltin RW; Fischman MW
Neuropsychopharmacology; 2001 Nov; 25(5):757-65. PubMed ID: 11682259
[TBL] [Abstract][Full Text] [Related]
9. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
[TBL] [Abstract][Full Text] [Related]
10. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
11. Effects of THC on behavioral measures of impulsivity in humans.
McDonald J; Schleifer L; Richards JB; de Wit H
Neuropsychopharmacology; 2003 Jul; 28(7):1356-65. PubMed ID: 12784123
[TBL] [Abstract][Full Text] [Related]
12. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
Haney M; Rabkin J; Gunderson E; Foltin RW
Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
[TBL] [Abstract][Full Text] [Related]
13. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
Hart CL; Haney M; Vosburg SK; Comer SD; Foltin RW
Psychopharmacology (Berl); 2005 Sep; 181(2):237-43. PubMed ID: 15830233
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
Haney M; Ramesh D; Glass A; Pavlicova M; Bedi G; Cooper ZD
Neuropsychopharmacology; 2015 Oct; 40(11):2489-98. PubMed ID: 25881117
[TBL] [Abstract][Full Text] [Related]
15. Marijuana withdrawal in humans: effects of oral THC or divalproex.
Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
[TBL] [Abstract][Full Text] [Related]
16. Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2014 Oct; 143():141-8. PubMed ID: 25124305
[TBL] [Abstract][Full Text] [Related]
17. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC
J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Greenwald MK; Stitzer ML
Drug Alcohol Depend; 2000 Jun; 59(3):261-75. PubMed ID: 10812286
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
20. Are choice and self-administration of marijuana related to delta 9-THC content?
Kelly TH; Foltin RW; Emurian CS; Fischman MW
Exp Clin Psychopharmacol; 1997 Feb; 5(1):74-82. PubMed ID: 9234042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
